Fieldpoint Private Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fieldpoint Private Securities's LLY Position: Q2 2022 in Review
Fieldpoint Private Securities increased its Eli Lilly (LLY) stake by 101% in Q2 2022, buying an estimated $778K and bringing the position to 5,152 shares worth $1.67M. The position accounts for 0.48% of the portfolio, ranked #49.
Fieldpoint Private Securities first reported a position in LLY in Q1 2017 and has held it in 21 quarters since. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- Fieldpoint Private Securities held 5,152 shares of Eli Lilly worth $1.67M as of Q2 2022.
- Fieldpoint Private Securities bought 2,592 Eli Lilly shares in Q2 2022, an estimated $778K.
- Eli Lilly made up 0.48% of Fieldpoint Private Securities's portfolio in Q2 2022, its #49 holding.
- Fieldpoint Private Securities first reported a position in Eli Lilly in Q1 2017 and has held it in 21 quarters since.
- 2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.